IL96243A - A transdermal drug system containing bonfernorphine as an active ingredient - Google Patents

A transdermal drug system containing bonfernorphine as an active ingredient

Info

Publication number
IL96243A
IL96243A IL9624390A IL9624390A IL96243A IL 96243 A IL96243 A IL 96243A IL 9624390 A IL9624390 A IL 9624390A IL 9624390 A IL9624390 A IL 9624390A IL 96243 A IL96243 A IL 96243A
Authority
IL
Israel
Prior art keywords
transdermal therapeutic
therapeutic system
buprenorphine
polymeric material
reservoir layer
Prior art date
Application number
IL9624390A
Other languages
English (en)
Hebrew (he)
Other versions
IL96243A0 (en
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6394373&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL96243(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL96243A0 publication Critical patent/IL96243A0/xx
Publication of IL96243A publication Critical patent/IL96243A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Laminated Bodies (AREA)
IL9624390A 1989-11-29 1990-11-05 A transdermal drug system containing bonfernorphine as an active ingredient IL96243A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939376A DE3939376C1 (sh) 1989-11-29 1989-11-29

Publications (2)

Publication Number Publication Date
IL96243A0 IL96243A0 (en) 1991-08-16
IL96243A true IL96243A (en) 1994-11-28

Family

ID=6394373

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9624390A IL96243A (en) 1989-11-29 1990-11-05 A transdermal drug system containing bonfernorphine as an active ingredient

Country Status (25)

Country Link
EP (1) EP0430019B1 (sh)
JP (1) JPH0818984B2 (sh)
KR (1) KR950015061B1 (sh)
AT (1) ATE135205T1 (sh)
AU (1) AU632182B2 (sh)
CA (1) CA2030178C (sh)
CZ (1) CZ282557B6 (sh)
DE (2) DE3939376C1 (sh)
DK (1) DK0430019T3 (sh)
ES (1) ES2086353T3 (sh)
FI (1) FI100379B (sh)
GR (1) GR3020177T3 (sh)
HR (1) HRP930675B1 (sh)
HU (1) HU206266B (sh)
IE (1) IE73247B1 (sh)
IL (1) IL96243A (sh)
MY (1) MY105347A (sh)
NO (1) NO303107B1 (sh)
NZ (1) NZ236191A (sh)
PL (1) PL165396B1 (sh)
PT (1) PT96028B (sh)
SI (1) SI9012260B (sh)
SK (1) SK279687B6 (sh)
YU (1) YU47956B (sh)
ZA (1) ZA909544B (sh)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5762952A (en) * 1993-04-27 1998-06-09 Hercon Laboratories Corporation Transdermal delivery of active drugs
DE4446600A1 (de) * 1994-12-24 1996-06-27 Lohmann Therapie Syst Lts Transdermale Resorption von Wirkstoffen aus unterkühlten Schmelzen
US6344211B1 (en) 1994-12-24 2002-02-05 Lts Lohmann Therapie-Systeme Gmbh Transdermal absorption of active substances from subcooled melts
JPH1036265A (ja) * 1996-07-19 1998-02-10 Nitto Denko Corp ブプレノルフィン経皮吸収製剤
DE19705138A1 (de) 1997-02-11 1998-08-13 Lohmann Therapie Syst Lts Dehnbares transdermales therapeutisches System
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
DE19738855C2 (de) 1997-09-05 2001-01-04 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
DE19850517B4 (de) 1998-11-03 2004-02-12 Lts Lohmann Therapie-Systeme Ag Verwendung eines wirkstoffhaltigen transdermalen therapeutischen Systems in einer Kombinationsbehandlung mit und ohne Ultraschall
DE19901085C2 (de) * 1999-01-14 2003-12-18 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps
DE19923551A1 (de) * 1999-05-21 2000-11-30 Lohmann Therapie Syst Lts Pharmazeutisches Präparat mit dem Wirkstoff Diamorphin und seine Verwendung in einem Verfahren zur Behandlung der Opiatsucht
DE10056014A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Mehrschichtige Trägerkonstruktion für wirkstofhaltige Pflastersyteme
DE10056012A1 (de) * 2000-11-11 2002-05-16 Beiersdorf Ag Flexible Barrierefolie für ein Trägermaterial für medizinische Zwecke
JP4194277B2 (ja) 2002-01-25 2008-12-10 久光製薬株式会社 架橋ポリマーを主成分とする粘着性成形体の製造方法
AU2003283055A1 (en) * 2002-08-09 2004-02-25 Grunenthal Gmbh Opioid-receptor antagonists in transdermal systems having buprenorphine
DE10237057A1 (de) * 2002-08-09 2004-03-25 Grünenthal GmbH Opioid-Rezeptor-Antagonisten in Pflasterformulierungen
MXPA05010450A (es) 2003-03-31 2005-11-04 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para la liberacion prolongada de agonistas de dopamina.
GEP20125454B (en) 2003-07-25 2012-03-26 Euro Celtique Sa Treatment of drug dependence withdrawal
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
EP1743638A1 (en) 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Pharmaceutical formulations of substituted pyrazoline compounds
DE102006057083A1 (de) 2005-12-05 2007-06-28 Lg Electronics Inc. Beleuchtungsvorrichtung für einen Kühlschrank
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
CA2815898C (en) 2010-11-17 2018-12-18 Hexal Ag Transdermal therapeutic system comprising buprenorphine
DE102011076653A1 (de) 2011-05-27 2012-11-29 Acino Ag Transdermales therapeutisches System enthaltend Buprenorphin und eine alpha-Hydroxysäure
AP4036A (en) * 2011-12-12 2017-02-22 Lohmann Therapie Syst Lts Transdermal delivery system comprising buprenorphine
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
EP3106153A1 (en) 2013-06-04 2016-12-21 LTS LOHMANN Therapie-Systeme AG Transdermal delivery system
DE102014013448A1 (de) 2014-09-16 2016-03-17 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales Therapeutisches System umfassend Buprenorphin
US9656441B2 (en) 2015-01-08 2017-05-23 Alfred E. Tiefenbacher ( Gmbh & Co. Kg) Transdermal patch
EP3067050A1 (en) 2015-03-13 2016-09-14 Acino AG Transdermal therapeutic system with an overtape comprising two adhesive layers
CN109045341A (zh) * 2018-05-07 2018-12-21 武汉兴嘉业堂医疗科技发展有限公司 一种活血止痛压敏胶及其制备方法、应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
JPS60123417A (ja) * 1983-12-07 1985-07-02 Nitto Electric Ind Co Ltd 薬物投与部材
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4806341A (en) * 1985-02-25 1989-02-21 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
JPS632533A (ja) * 1986-06-23 1988-01-07 Yamakawa Sangyo Kk 精密鋳造用鋳物砂
CH672888A5 (sh) * 1986-11-07 1990-01-15 Mepha Ag
ES2036670T3 (es) * 1987-03-09 1993-06-01 Alza Corporation Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante.
JPH02503672A (ja) * 1987-06-01 1990-11-01 ワーナー‐ランバート・コンパニー 水性の系における浸透促進剤としての脂肪酸およびその短鎖エステル
DE3843237A1 (de) * 1988-12-22 1990-07-05 Lohmann Therapie Syst Lts Transdermales therapeutisches system mit einem antiadipositum als aktivem bestandteil

Also Published As

Publication number Publication date
FI905892A0 (fi) 1990-11-29
NO905103L (no) 1991-05-30
JPH03193732A (ja) 1991-08-23
JPH0818984B2 (ja) 1996-02-28
AU632182B2 (en) 1992-12-17
CA2030178A1 (en) 1991-05-30
FI100379B (fi) 1997-11-28
PT96028B (pt) 1998-02-27
HRP930675B1 (en) 1999-10-31
MY105347A (en) 1994-09-30
GR3020177T3 (en) 1996-09-30
NO905103D0 (no) 1990-11-26
PL165396B1 (en) 1994-12-30
ES2086353T3 (es) 1996-07-01
HUT55643A (en) 1991-06-28
YU47956B (sh) 1996-07-24
EP0430019A2 (de) 1991-06-05
CS9005598A2 (en) 1991-12-17
FI905892A (fi) 1991-05-30
DE59010192D1 (de) 1996-04-18
CA2030178C (en) 1995-08-15
IE904290A1 (en) 1991-06-05
SI9012260B (sl) 1998-06-30
KR950015061B1 (ko) 1995-12-21
EP0430019B1 (de) 1996-03-13
DK0430019T3 (da) 1996-07-22
AU6569990A (en) 1991-06-06
HU206266B (en) 1992-10-28
YU226090A (sh) 1992-12-21
SK279687B6 (sk) 1999-02-11
IL96243A0 (en) 1991-08-16
NZ236191A (en) 1993-05-26
PL287989A1 (en) 1991-09-09
ATE135205T1 (de) 1996-03-15
DE3939376C1 (sh) 1991-05-08
EP0430019A3 (en) 1991-09-18
SI9012260A (en) 1997-10-31
IE73247B1 (en) 1997-05-21
ZA909544B (en) 1992-08-26
CZ282557B6 (cs) 1997-08-13
NO303107B1 (no) 1998-06-02
KR910009249A (ko) 1991-06-28
HRP930675A2 (en) 1994-10-31
PT96028A (pt) 1991-09-13

Similar Documents

Publication Publication Date Title
US5240711A (en) Transdermal therapeutic system comprising as active component buprenorphine
CA2030178C (en) Transdermal therapeutic system comprising as active component buprenorphine
US5700480A (en) Transdermal therapeutic system comprising galanthamine as active component
JPH041127A (ja) 医療用貼付剤
WO2007099966A1 (ja) 経皮吸収型製剤
US20090264806A1 (en) Transdermal drug administration device
KR20050005551A (ko) 접착제
EP1733719B2 (en) Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure
JP2002537244A (ja) デオキシペガニン経皮治療系
TW201811318A (zh) 一種包含葛蘭他命或其醫藥用鹽類的穿皮釋放系統
JP3066515B2 (ja) 尿失禁治療用経皮投与製剤
CA2006425C (en) Transdermal therapeutical system comprising norpseudoephedrine as active component
JP2006022057A (ja) 経皮吸収製剤用基剤およびこれを用いた皮膚貼付製剤
JPH0776526A (ja) 乳酸エステルを含有する経皮吸収製剤
JPH07116025B2 (ja) 貼付剤
KR20040044907A (ko) 에날라프릴 에스테르의 경피 투여
JP2596539B2 (ja) 経皮・経粘膜製剤
JP6864968B2 (ja) 貼付剤
WO1993011767A1 (en) Transdermal delivery of (e)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-o-methyloxine hcl and related compounds in the treatment of cognitive disorders and for analgesia
JPS60184010A (ja) 経皮投与用医薬製剤
KR20010005871A (ko) 경피흡수용 기제조성물 및 이 기제조성물을 함유하는 경피흡수제제

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
FF Patent granted
EXP Patent expired